DEBRA FENDERSON-IVERY: Open Payments
NPI 1902306624 · HAINESPORT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 41 payments from 12 companies in 2025. Trend: 2023 $725 · 2024 $1,030 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 3 | $226 |
| Collegium Pharmaceutical, Inc. | 12 | $151 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $141 |
| Saluda Medical Americas, Inc. | 4 | $117 |
| Abbott Laboratories | 4 | $109 |
| PROTEGA PHARMACEUTIALS INC | 3 | $42 |
| SCILEX PHARMACEUTICALS INC. | 2 | $36 |
| Valinor Pharma, LLC | 1 | $20 |
| Forte Bio-Pharma LLC | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: QUTENZA, RELISTOR, Evoke, Belbuca, PROCLAIM, ROXYBOND, XTAMPZA, ETERNA.
Industry payments across NJ — which companies pay providers there.
